Manufacturing Daily Summary
Manufacturing Daily Summary: What Happened on October 9, 2026
Bio-Techne opens Bristol GMP site for cell therapy materials
The 10,000-square-foot facility is fully operational, with seven cleanrooms for small-molecule production and handling.
Today in brief
Bio-Techne’s new Bristol site is now making GMP-grade small molecules for cell therapy developers worldwide.1 It has two ISO-7 cleanrooms and five ISO-8 cleanrooms.1
A new manufacturing site in Bristol
Bio-Techne opened a purpose-built, fully operational facility to make materials for cell therapy developers.1 The company established the site to help developers standardize workflows, limit variation between batches and expand production as regulatory expectations change.1
Also published
- The Most Important Lessons Learned from Building CGT Supply Chains: LogiPharma 2026 Pharmaceutical Executive
- Bio-Techne opens GMP manufacturing facility in Bristol to support cell therapy development BioProcess International